1 / 18

Primary ESRD Modality in New ESRD Patients, 1995-97*

IV -1. USRDS 1999. Primary ESRD Modality in New ESRD Patients, 1995-97*. New Patients (%). *Reported on HCFA Medical Evidence Form. IV -2. USRDS 1999. Demographic Characteristics of New ESRD Patients, 1997*. New Patients (Age or %).

jemima
Download Presentation

Primary ESRD Modality in New ESRD Patients, 1995-97*

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IV -1 USRDS 1999 Primary ESRD Modality in New ESRD Patients, 1995-97* New Patients (%) *Reported on HCFA Medical Evidence Form

  2. IV -2 USRDS 1999 Demographic Characteristics of New ESRD Patients, 1997* New Patients (Age or %) Average Age % Male % Diabetes** *Reported on HCFA Medical Evidence Form **Primary/contributing cause of ESRD

  3. IV -3 USRDS 1999 Reported Race and Hispanic Ethnicity among New ESRD Patients, 1997* New Patients (%) Number of People Middle Indian Other/ East Subcontinent Multicultural WhiteBlack Asian / Native American /Other Pacific Islander Alaskan Native *Reported on HCFA Medical Evidence Form Unknown race is not included in percentages. Approximately 0.6% of patients reported race as “Unknown”.

  4. IV - 4 USRDS 1999 Primary Detailed Disease Groups Reported among New ESRD Patients, 1997* New Patients (%) Diabetes Hyper- Glomerulo- Secondary Interstitial Cystic/ Neoplasms/ Miscel- tension nephritis GN/ Vascu- Nephritis Hereditary/ Tumors laneous litisPyelo- Congenital Nephritis *Reported on HCFA Medical Evidence Form

  5. IV -5 USRDS 1999 Primary Disease Reported among New ESRD Patients by Year, 1995-97* New Patients (%) Diabetes Hypertension Glomerulo- Cystic Other Causes nephritis Kidney Disease *Reported on HCFA Medical Evidence Form

  6. IV -6 USRDS 1999 Cardiovascular Patient Characteristics among New Dialysis Patients, 1997* New Patients (%) Congestive CAD MI Cardiac CVD / Peripheral Heart Arrest CVA/ Vascular Failure TIA Disease *Reported on HCFA Medical Evidence Form

  7. Gender Diabetes IV -7 USRDS 1999 Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Gender and Diabetes in New Dialysis Patients, 1997* New Patients (%) Male Female Yes No *Reported on HCFA Medical Evidence Form

  8. IV -8 USRDS 1999 Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Age for New Dialysis Patients, 1997* New Patients (%) 20-44 45-64 65-74 75+ Age *Reported on HCFA Medical Evidence Form

  9. IV -9 USRDS 1999 Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Race and Hispanic Ethnicity in New Dialysis Patients, 1997* New Patients (%) White Black Asian Native Other Hispanic Non- American Hispanic *Reported on HCFA Medical Evidence Form

  10. IV -10 USRDS 1999 Non-Cardiovascular Patient Characteristics among New Dialysis Patients, 1997* New Patients (%) Diabetes COPD Cancer Smoker Inability to Inability to on insulin Ambulate Transfer *Reported on HCFA Medical Evidence Form

  11. Average BMI (kg/m2) Average Serum Albumin (g/dl) IV -11 USRDS 1999 Serum Albumin and Body Mass Index (BMI)for New ESRD Patients, 1995-98* 1995 1996 1997 1998 1995 1996 1997 1998 *Reported on HCFA Medical Evidence Form; 1998 data are through June

  12. IV -12 USRDS 1999 Distribution of Facilities by Average Number of Comorbidities Reported per Patient, 1995-97* Facilities (%) 0 <1 1 to <2 2 to <3 3 to <4 4 to <5 5 to <6 Average Number of Comorbidities Reported *Reported on HCFA Medical Evidence Form **Excludes facilities with < 5 new patients in 3 years

  13. IV -13 USRDS 1999 Distribution of Facilities by Percent of Patients with Zero Comorbidities Reported, 1995-97* Facilities (%) Percent of Patients with Zero Comorbidities Reported *Reported on HCFA Medical Evidence Form **Excludes facilities with < 5 new patients in 3 years

  14. Average Serum Creatinine (mg/dl) Average GFR (ml/min)** 20-44 45-64 65-74 75+ 20-44 45-64 65-74 75+ Age Age IV -14 USRDS 1999 Serum Creatinine and GFRfor New ESRD Patients by Age Group, 1995-97* *Reported on HCFA Medical Evidence Form **MDRD Formula

  15. Average Serum Creatinine (mg/dl) Average Weight (kg) IV -15 USRDS 1999 Serum Creatinine and Weightfor New ESRD Patients by Year, 1995-98* 1995 1996 1997 1998 1995 1996 1997 1998 *Reported on HCFA Medical Evidence Form; 1998 data are through June

  16. IV -16 USRDS 1999 EPO Use Before ESRD by Age and Gender for New ESRD Patients, 1995-97* Receiving EPO Before ESRD (%) 20-44 45-64 65-74 75+ Female Male Age Gender *Reported on HCFA Medical Evidence Form

  17. IV -17 USRDS 1999 EPO Use Before ESRD for New ESRD Patientsby Race and Hispanic Ethnicity, 1995-97* Receiving EPO Before ESRD (%) White Black Asian Native Other Hispanic Non- American Hispanic *Reported on HCFA Medical Evidence Form

  18. 6 months before ESRD (missing = 10%) At onset of ESRD (missing = 4%) IV -18 USRDS 1999 Prior vs. Current Employment among New ESRD Patients, Ages 20-64, 1997* New Patients (%) Employed** Unemployed Retired, Retired Homemaker Medical Student Disabled by Age Leave *Reported on HCFA Medical Evidence Form. **Includes part-time and full-time. Patients with employment status missing are excluded.

More Related